{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:32:53Z","timestamp":1786692773087,"version":"build-2736575974"},"reference-count":24,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>IDH1 mutations occur in approximately 10%\u201320% of intrahepatic cholangiocarcinoma (iCCA) and constitute an established target for molecularly guided therapy. As routine molecular diagnostics are commonly based on a single tumour sample, intratumoral heterogeneity could affect the reliable detection of actionable mutations. This study assessed the spatial heterogeneity of IDH1 mutations in iCCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with histologically confirmed iCCA who underwent routine next\u2010generation sequencing (NGS) and had multiple available formalin\u2010fixed paraffin\u2010embedded (FFPE) tumour samples were retrospectively analysed. Baseline IDH1 status was determined by NGS. All available tumour regions were subsequently tested using the Idylla\u2122 IDH1\u20102 Mutation Assay. Blocks where the Idylla\u2122 IDH1 mutational status was discordant with baseline status were validated by digital polymerase chain reaction (dPCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty\u2010five patients with iCCA were included, yielding 117 FFPE samples from spatially distinct tumour regions. Baseline NGS identified IDH1 mutations in 22.8% (8\/35) of patients. Idylla\u2122 testing revealed discordant results in 5 of 117 samples (4.2%). Validation by dPCR demonstrated that these discordances were attributable to technical limitations or assay\u2010related errors rather than true biological heterogeneity. Following validation, all IDH1\u2010mutated tumours showed concordant mutation status across all analysed tumour regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IDH1 mutations appear to be spatially homogeneous in iCCA, supporting their role as an early clonal event. These findings indicate that single\u2010sample molecular testing is sufficient for reliable determination of IDH1 status and patient selection for IDH1\u2010targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/his.70266","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:14:47Z","timestamp":1786691687000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral\n                    <scp>IDH1<\/scp>\n                    mutation status in intrahepatic cholangiocarcinoma is homogeneous"],"prefix":"10.1111","author":[{"given":"Sharon","family":"Weidmann","sequence":"first","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Ebner","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institutes of Pathology, Neuropathology and Human Genetics University Medical Center Frankfurt, Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8199-5270","authenticated-orcid":false,"given":"Aayushi","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Wiegering","sequence":"additional","affiliation":[{"name":"Department of General, Visceral, Transplant and Thoracic Surgery, University Hospital Frankfurt Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0845-6833","authenticated-orcid":false,"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1017-3744","authenticated-orcid":false,"given":"Peter J.","family":"Wild","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institutes of Pathology, Neuropathology and Human Genetics University Medical Center Frankfurt, Goethe University Frankfurt  Frankfurt am Main Germany"},{"name":"Frankfurt Institute for Advanced Studies (FIAS)  Frankfurt am Main Germany"},{"name":"Frankfurt Cancer Institute (FCI) Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-1455","authenticated-orcid":false,"given":"Maximilian N.","family":"Kinzler","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie C.","family":"Winter","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institutes of Pathology, Neuropathology and Human Genetics University Medical Center Frankfurt, Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2309-9624","authenticated-orcid":false,"given":"Dirk","family":"Walter","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt Goethe University Frankfurt  Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle J","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"e_1_2_13_3_1","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh DY","year":"2022","journal-title":"NEJM Evid."},{"key":"e_1_2_13_4_1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/his.70116","article-title":"Changes in the 6th edition of the world health organization classification of tumours of the digestive system","volume":"88","author":"Arends MJ","year":"2026","journal-title":"Histopathology"},{"key":"e_1_2_13_5_1","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: Potential targets for intervention","volume":"24","author":"Lowery MA","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_13_6_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101635","article-title":"Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study","volume":"8","author":"Welland S","year":"2026","journal-title":"JHEP Rep"},{"key":"e_1_2_13_7_1","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1007\/s00432-023-04603-7","article-title":"Impact of idh1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: A retrospective analysis from a german tertiary center","volume":"149","author":"Kinzler MN","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"e_1_2_13_8_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40880-018-0302-3","article-title":"Metabolic recoding of epigenetics in cancer","volume":"38","author":"Wang YP","year":"2018","journal-title":"Cancer Commun. (Lond.)"},{"key":"e_1_2_13_9_1","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"Wang P","year":"2013","journal-title":"Oncogene"},{"key":"e_1_2_13_10_1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in idh1\u2010mutant, chemotherapy\u2010refractory cholangiocarcinoma (claridhy): A multicentre, randomised, double\u2010blind, placebo\u2010controlled, phase 3 study","volume":"21","author":"Abou\u2010Alfa GK","year":"2020","journal-title":"Lancet Oncol."},{"key":"e_1_2_13_11_1","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101230","article-title":"Idh mutation subgroup status associates with intratumor heterogeneity and the tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"8","author":"Xiang X","year":"2021","journal-title":"Adv. Sci."},{"key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12864-018-4829-0","article-title":"Transcriptomic analysis and mutational status of idh1 in paired primary\u2010recurrent intrahepatic cholangiocarcinoma","volume":"19","author":"Peraldo\u2010Neia C","year":"2018","journal-title":"BMC Genomics"},{"key":"e_1_2_13_13_1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.29764","article-title":"Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma","volume":"68","author":"Nepal C","year":"2018","journal-title":"Hepatology"},{"key":"e_1_2_13_14_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2018.02.029","article-title":"Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma","volume":"69","author":"Dong LQ","year":"2018","journal-title":"J. Hepatol."},{"key":"e_1_2_13_15_1","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1038\/s41467-025-59156-9","article-title":"Genomic landscape of diffuse glioma revealed by whole genome sequencing","volume":"16","author":"Kinnersley B","year":"2025","journal-title":"Nat. Commun."},{"key":"e_1_2_13_16_1","first-page":"17","article-title":"Evaluation of an idh1\/2 mutation fasttrack assay for patients with cholangiocarcinoma","volume":"17","author":"Winter M","year":"2025","journal-title":"Cancer"},{"key":"e_1_2_13_17_1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","article-title":"Idh1 mutations are early events in the development of astrocytomas and oligodendrogliomas","volume":"174","author":"Watanabe T","year":"2009","journal-title":"Am. J. Pathol."},{"key":"e_1_2_13_18_1","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.28.3762","article-title":"Idh1 and idh2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with npm1 mutation without flt3 internal tandem duplication","volume":"28","author":"Paschka P","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_13_19_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer\u2010associated idh1 mutations produce 2\u2010hydroxyglutarate","volume":"462","author":"Dang L","year":"2009","journal-title":"Nature"},{"key":"e_1_2_13_20_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia\u2010associated idh1 and idh2 mutations is a neomorphic enzyme activity converting alpha\u2010ketoglutarate to 2\u2010hydroxyglutarate","volume":"17","author":"Ward PS","year":"2010","journal-title":"Cancer Cell"},{"key":"e_1_2_13_21_1","doi-asserted-by":"crossref","first-page":"14957","DOI":"10.18632\/oncotarget.14844","article-title":"Intratumoral heterogeneity of intrahepatic cholangiocarcinoma","volume":"8","author":"Walter D","year":"2017","journal-title":"Oncotarget"},{"key":"e_1_2_13_22_1","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1038\/s41598-025-95142-3","article-title":"Whole exome sequencing of multi\u2010regions reveals tumor heterogeneity in opisthorchis viverrini\u2010associated cholangiocarcinoma","volume":"15","author":"Sitthirak S","year":"2025","journal-title":"Sci. Rep."},{"key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1158\/1538-7445.AM2019-2275","article-title":"Abstract 2275: Detection of idh1 mutations in plasma cell\u2010free circulating tumor DNA (ctdna) from patients with cholangiocarcinoma","volume":"79","author":"Aguado\u2010Fraile E","year":"2019","journal-title":"Cancer Res."},{"key":"e_1_2_13_24_1","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1200\/JCO.2020.38.15_suppl.4576","article-title":"Idh1 mutation detection in plasma circulating tumor DNA (ctdna) and association with clinical response in patients with advanced intrahepatic cholangiocarcinoma (ihc) from the phase iii claridhy study","volume":"38","author":"Aguado E","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_13_25_1","first-page":"11","article-title":"Assessment of a high sensitivity method for identification of idh1 r132x mutations in tumors and plasma of intrahepatic cholangiocarcinoma patients","volume":"11","author":"Peraldo\u2010Neia C","year":"2019","journal-title":"Cancer"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70266","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/his.70266","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:14:51Z","timestamp":1786691691000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/his.70266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":24,"alternative-id":["10.1111\/his.70266"],"URL":"https:\/\/doi.org\/10.1111\/his.70266","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2026-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"his.70266"}}